Gillian Lowe

2.2k total citations
44 papers, 965 citations indexed

About

Gillian Lowe is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Gillian Lowe has authored 44 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Genetics. Recurrent topics in Gillian Lowe's work include Platelet Disorders and Treatments (26 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Gillian Lowe is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Gillian Lowe collaborates with scholars based in United Kingdom, United States and France. Gillian Lowe's co-authors include Steve P. Watson, Marie Lordkipanidzé, Neil V. Morgan, Martina E. Daly, Danai Bem, Ban B. Dawood, Andrew Mumford, Vincenzo Leo, Jonathan T. Wilde and Michael Makris and has published in prestigious journals such as Journal of Clinical Investigation, Blood and British Journal of Haematology.

In The Last Decade

Gillian Lowe

35 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Lowe United Kingdom 17 689 189 189 149 119 44 965
Nicole Allen United States 9 113 0.2× 104 0.6× 125 0.7× 163 1.1× 157 1.3× 17 657
Yves Pastore Canada 17 477 0.7× 402 2.1× 33 0.2× 123 0.8× 303 2.5× 60 1.1k
Vera Großmann Germany 17 523 0.8× 363 1.9× 58 0.3× 76 0.5× 411 3.5× 43 1.1k
M Matucci Cerinic Italy 17 207 0.3× 68 0.4× 35 0.2× 138 0.9× 117 1.0× 47 784
Fiorina Giona Italy 23 590 0.9× 374 2.0× 33 0.2× 80 0.5× 331 2.8× 88 1.3k
Rosario Foti Italy 16 170 0.2× 76 0.4× 134 0.7× 183 1.2× 85 0.7× 93 986
L Dunlop Australia 10 274 0.4× 39 0.2× 52 0.3× 148 1.0× 125 1.1× 17 630
D. Adoué France 17 215 0.3× 144 0.8× 25 0.1× 112 0.8× 152 1.3× 75 884
Azza Abdel Gawad Tantawy Egypt 17 384 0.6× 307 1.6× 48 0.3× 30 0.2× 171 1.4× 75 858
Cassandra Brookes United Kingdom 12 209 0.3× 158 0.8× 61 0.3× 32 0.2× 198 1.7× 36 842

Countries citing papers authored by Gillian Lowe

Since Specialization
Citations

This map shows the geographic impact of Gillian Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Lowe more than expected).

Fields of papers citing papers by Gillian Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Lowe. The network helps show where Gillian Lowe may publish in the future.

Co-authorship network of co-authors of Gillian Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Lowe. A scholar is included among the top collaborators of Gillian Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Lowe. Gillian Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fratter, Carl, Will Lester, Charles Percy, et al.. (2025). The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience. Research and Practice in Thrombosis and Haemostasis. 9(3). 102869–102869.
2.
Saultier, Paul, Laurent Frenzel, Roger E. G. Schutgens, et al.. (2025). Sutacimig, a novel bispecific antibody for prophylactic treatment of glanzmann thrombasthenia: Analysis of a Phase 2 study. Blood. 146(Supplement 1). 842–842.
3.
4.
Leavitt, Andrew D., Johnny Mahlangu, Emily Symington, et al.. (2025). Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1. Hämostaseologie. 45.
5.
Buka, Richard J., Bryar Kadir, Andrew J. Doyle, et al.. (2024). Rapido: Results from a UK-Wide Audit of 2477 Patients Who Received a Reversal Agent for a Direct Oral Anticoagulant. Blood. 144(Supplement 1). 2637–2637.
6.
Mistry, Jayna J., et al.. (2024). Sustained good response to rituximab in acquired von Willebrand syndrome. Blood Coagulation & Fibrinolysis. 35(3). 147–149.
7.
Lowe, Gillian, Lone Hvitfeldt Poulsen, Susan Shapiro, et al.. (2023). Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries. Advances in Therapy. 40(9). 3770–3783. 4 indexed citations
8.
Kemble, Samuel, Amanda Dalby, Gillian Lowe, et al.. (2022). Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry. Blood Advances. 6(9). 2932–2946. 12 indexed citations
9.
Desborough, Michael, et al.. (2022). Outcomes and management of pregnancy in women with bleeding disorder of unknown cause. Journal of Thrombosis and Haemostasis. 20(11). 2519–2525. 11 indexed citations
10.
Kenet, Gili, Yeu‐Chin Chen, Gillian Lowe, et al.. (2021). Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study. Journal of Clinical Medicine. 10(24). 5959–5959. 16 indexed citations
11.
12.
Nicolson, Phillip L.R., et al.. (2017). Mild bleeding disorders: what every clinician should know. British Journal of Hospital Medicine. 78(12). 684–710. 1 indexed citations
13.
Patel, Yesha, Marie Lordkipanidzé, Gillian Lowe, et al.. (2014). A novel mutation in the P2Y12 receptor and a function‐reducing polymorphism in protease‐activated receptor 1 in a patient with chronic bleeding. Journal of Thrombosis and Haemostasis. 12(5). 716–725. 36 indexed citations
14.
Dovlatova, Natalia, Marie Lordkipanidzé, Gillian Lowe, et al.. (2014). Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders. Journal of Thrombosis and Haemostasis. 12(5). 660–665. 39 indexed citations
15.
Leo, Vincenzo, Neil V. Morgan, Danai Bem, et al.. (2014). Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders. Journal of Thrombosis and Haemostasis. 13(4). 643–650. 52 indexed citations
16.
Nisar, Shaista P., Marie Lordkipanidzé, Matthew L. Jones, et al.. (2014). A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction. Thrombosis and Haemostasis. 112(5). 923–932. 17 indexed citations
17.
Stockley, Jacqueline, Neil V. Morgan, Danai Bem, et al.. (2013). Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood. 122(25). 4090–4093. 79 indexed citations
18.
Lowe, Gillian, Marie Lordkipanidzé, Ban B. Dawood, et al.. (2013). OC-13 Investigation of underlying platelet function defects in patients with unexplained menorrhagia. Thrombosis Research. 131. S74–S74. 2 indexed citations
19.
Lowe, Gillian, Marie Lordkipanidzé, & Steve P. Watson. (2013). Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. Journal of Thrombosis and Haemostasis. 11(9). 1663–1668. 80 indexed citations
20.
Dawood, Ban B., Gillian Lowe, Marie Lordkipanidzé, et al.. (2012). Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood. 120(25). 5041–5049. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Allen Breakdown of academic impact, for papers by Yves Pastore Breakdown of academic impact, for papers by Vera Großmann Breakdown of academic impact, for papers by M Matucci Cerinic Breakdown of academic impact, for papers by Fiorina Giona Breakdown of academic impact, for papers by Rosario Foti Breakdown of academic impact, for papers by L Dunlop Breakdown of academic impact, for papers by D. Adoué Breakdown of academic impact, for papers by Azza Abdel Gawad Tantawy Breakdown of academic impact, for papers by Cassandra Brookes
Rankless by CCL
2026